Abstract:One promoter polymorphism, −174G/C, in interleukin-6 gene attracts special attention for its involvement in regulating transcription and association with hypertension by several studies. We first performed a case–control study investigating the association of this polymorphism with essential hypertension among Han Chinese (475 cases and 475 controls, matched for age and gender) from Shanghai, and then meta-analyzed all available evidence. Genotyping was done using PCR-RFLP techniques. Three genetic modes of inheritance were explored. As for meta-analysis, fixed-effects model was applied to pool data in the absence of between-studies heterogeneity, and random-effects model otherwise. Data and study quality were assessed in duplicate. Publication bias was evaluated using the fail-safe number. Our case–control study showed significant differences in the genotype/allele distributions of −174G/C polymorphism, and significance persisted under both additive and dominant modes. The following meta-analysis involving 1153 cases and 1291 controls supported the protective role of −174C allele (OR=0.77; 95% CI, 0.58 to 1.00; P=0.05), in line with the represent case–control results. In addition, significance was noted for the dominant effect (OR=0.69; 95% CI, 0.49 to 0.97; P<0.0001) rather than the recessive effect (OR=0.80; 95% CI, 0.56 to 1.13; P=0.20). The fail-safe number at the level of 0.05 was in favor of this positive association. Taken together, our case–control study and meta-analysis consistently support that the −174C allele was associated with a decreased risk to develop hypertension and this effect appeared to manifest in a dominant action. One promoter polymorphism, −174G/C, in interleukin-6 gene attracts special attention for its involvement in regulating transcription and association with hypertension by several studies. We first performed a case–control study investigating the association of this polymorphism with essential hypertension among Han Chinese (475 cases and 475 controls, matched for age and gender) from Shanghai, and then meta-analyzed all available evidence. Genotyping was done using PCR-RFLP techniques. Three genetic modes of inheritance were explored. As for meta-analysis, fixed-effects model was applied to pool data in the absence of between-studies heterogeneity, and random-effects model otherwise. Data and study quality were assessed in duplicate. Publication bias was evaluated using the fail-safe number. Our case–control study showed significant differences in the genotype/allele distributions of −174G/C polymorphism, and significance persisted under both additive and dominant modes. The following meta-analysis involving 1153 cases and 1291 controls supported the protective role of −174C allele (OR=0.77; 95% CI, 0.58 to 1.00; P=0.05), in line with the represent case–control results. In addition, significance was noted for the dominant effect (OR=0.69; 95% CI, 0.49 to 0.97; P<0.0001) rather than the recessive effect (OR=0.80; 95% CI, 0.56 to 1.13; P=0.20). The fail-safe number at the level of 0.05 was in favor of this positive association. Taken together, our case–control study and meta-analysis consistently support that the −174C allele was associated with a decreased risk to develop hypertension and this effect appeared to manifest in a dominant action.

A Functional Single-Nucleotide Polymorphism In Interleukin-6 Promoter Is Associated With P Wave Dispersion In Hypertensive Subjects With Atrial Fibrillation

Effect of Interleukin-27 Genetic Variants on Atrial Fibrillation Susceptibility.

A Variant of IL6R is Associated with the Recurrence of Atrial Fibrillation after Catheter Ablation in a Chinese Han Population.

Association Between Polymorphisms in Interleukin-6 Gene Promoter Region and Coronary Artery Disease

Lack of an Association Between Interleukin-6-174g/C Polymorphism and Circulating Interleukin-6 Levels in Normal Population: A Meta-Analysis

The Association of Functional Polymorphisms of IL-6 Gene Promoter with Ischemic Stroke: Analysis in Two Chinese Populations.

Interleukin-6 Promoter −174G/C Polymorphism and Hypertension: A Case–control Study and a Meta-Analysis

Relationship Between Coronary Heart Disease and Polymorphisms of Interleukin-6 Gene

The Relationship Between Polymorphism of Interleukin-1Αc-889t and Patients with Coronary Heart Disease

Study on Linkage Between Polymorphism of Interleukin 6 Gene -572C/G and Susceptibility to Myocardial Infarction

The IL6R Gene Polymorphisms Are Associated with Sil-6R, IgE and Lung Function in Chinese Patients with Asthma.

Association of interleukin-6 gene-174G ＞ C polymorphisman with coronary heart disease of Chinese Han population in Nanjing area

Association of Interleukin-6 Gene -572C/G Single Nucleotide Polymorphism with Coronary Artery Disease in Han Population of North China

The Expression of Peroxisome Proliferator-Activated Receptor-Α and Β in Hypertensive Atrial Fibrillation

[Expression of Peroxisome Proliferator-Activated Receptor Alpha and Beta in Peripheral Blood Mononuclear Cells of Non-Vavular Hypertensive Atrial Fibrillation Patients].

Association of Interleukin-18 Gene Promoter Polymorphisms with Risk of Acute Myocardial Infarction in Northern Chinese Han Population

Distribution of interleukin-6-597G/A and -572C/G promoter gene polymorphisms in Hubei Hans population

Association Between Interleukin-6 Gene Polymorphisms and Primary Hypertension in Hubei Han Population

Interleukin-8 Gene Polymorphism Is Associated With Acute Coronary Syndrome In The Chinese Han Population

Interleukin-16 Gene Polymorphism Is Associated With Acute Coronary Syndrome In The Chinese Han Population

Interleukin 6 polymorphisms are associated with cardiovascular risk factors in premature coronary artery disease patients and healthy controls of the GEA Mexican study